Benefits and harms antiviral agents. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Cell Line Vero Cells Cells, Cultured HeLa Cells Cell Line, Tumor Capsid Liver CD8-Positive T-Lymphocytes L Cells (Cell Line)T-Lymphocytes, Cytotoxic CD4-Positive T-Lymphocytes HEK293 Cells

Organisms39

Hepacivirus HIV-1 Cercopithecus aethiops Cytomegalovirus Simplexvirus Viruses Influenza A Virus, H1N1 Subtype Influenza B virus Influenza A virus Orthomyxoviridae Hepatitis B virus HIV Herpesvirus 1, Human Herpesviridae Herpesvirus 2, Human Enterovirus A, Human Influenza A Virus, H3N2 Subtype Influenza A Virus, H5N1 Subtype Herpesvirus 3, Human Vesicular stomatitis Indiana virus Vaccinia virus Mice, Inbred BALB C Encephalomyocarditis virus Dogs SARS Virus Cricetinae Sendai virus Vesiculovirus Capsid Lymphocytic choriomeningitis virus RNA Viruses Mice, Inbred C57BL Mengovirus Rhinovirus Acanthopanax Muromegalovirus Enterovirus B, Human Sindbis Virus Mice, Knockout

Diseases24

Influenza, Human Virus Diseases Herpes Simplex Cytomegalovirus Infections Hepatitis B, Chronic Hepatitis C, Chronic Hepatitis C Eye Infections, Viral Hepatitis B HIV Infections Herpes Zoster Herpesviridae Infections Orthomyxoviridae Infections Disease Models, Animal Recurrence RNA Virus Infections Vesicular Stomatitis Rhabdoviridae Infections Lymphocytic Choriomeningitis Arenaviridae Infections Vaccinia Substance Abuse, Intravenous Viremia Neoplasms

Chemicals and Drugs86

Antiviral Agents Acyclovir Organophosphonates Rimantadine Amantadine Trifluridine Oseltamivir Interferons Nucleosides Ribavirin Zanamivir Ganciclovir Cytosine Foscarnet Interferon-alpha Prodrugs Idoxuridine RNA, Viral Organophosphorus Compounds Zalcitabine Anti-HIV Agents Ribonucleosides Adenine 2-Aminopurine Zidovudine Lamivudine Reverse Transcriptase Inhibitors Pyrans Viral Proteins Viral Nonstructural Proteins Arabinonucleotides Interferon Type I Vidarabine Phosphate DNA, Viral Arabinofuranosyluracil Vidarabine Neuraminidase Interferon-beta Dideoxynucleosides Isoxazoles Influenza Vaccines Myxovirus Resistance Proteins Protease Inhibitors Guanine Polyethylene Glycols RNA Replicase Recombinant Proteins HIV Protease Inhibitors Ribosome Inactivating Proteins, Type 1 Acetamides Guanidines 2',5'-Oligoadenylate Synthetase HIV Protease Interferon Regulatory Factor-3 Valine Thymidine Kinase HIV Reverse Transcriptase DEAD-box RNA Helicases RNA, Double-Stranded DNA-Directed DNA Polymerase Enzyme Inhibitors Amides Thymidine Peptides Oligopeptides Poly I-C Viral Envelope Proteins Recombinant Fusion Proteins Antineoplastic Agents Interferon Inducers eIF-2 Kinase Antibodies, Viral Receptors, Interferon Interferon-gamma STAT2 Transcription Factor Receptor, Interferon alpha-beta Cytidine Deaminase N-Glycosyl Hydrolases Toll-Like Receptor 3 STAT1 Transcription Factor Antigens, Viral Interferon Regulatory Factor-7 Plant Extracts RNA, Small Interfering vif Gene Products, Human Immunodeficiency Virus Cytokines

Analytical, Diagnostic and Therapeutic Techniques and Equipment36

Viral Plaque Assay Treatment Outcome Inhibitory Concentration 50 Drug Therapy, Combination Drug Evaluation, Preclinical Viral Load Drug Design Cytopathogenic Effect, Viral Models, Molecular Administration, Oral Microbial Sensitivity Tests Clinical Trials as Topic Administration, Topical Risk Factors Disease Models, Animal Randomized Controlled Trials as Topic Risk Assessment Models, Biological Liver Transplantation Polymerase Chain Reaction Retrospective Studies Magnetic Resonance Spectroscopy Transfection Chromatography, High Pressure Liquid Follow-Up Studies Prospective Studies Mass Screening Questionnaires Nontherapeutic Human Experimentation Survival Analysis Medication Errors Patient Selection Double-Blind Method Research Design Decision Support Techniques Cohort Studies

Psychiatry and Psychology5

Harm Reduction Self-Injurious Behavior Morals Substance Abuse, Intravenous Decision Making

Phenomena and Processes38

Virus Replication Drug Resistance, Viral Inhibitory Concentration 50 Virus Internalization Time Factors Viral Load Cytopathogenic Effect, Viral Structure-Activity Relationship Replicon Amino Acid Sequence Virus Activation Molecular Structure Dose-Response Relationship, Drug Mutation Immunity, Innate Virus Assembly Genotype Base Sequence Immunocompromised Host Drug Resistance, Microbial Protein Binding RNA, Double-Stranded Host-Pathogen Interactions Cell Survival Drug Synergism Binding Sites Kinetics Pregnancy RNA Interference Signal Transduction Protein Conformation Virus Physiological Phenomena Transfection Substrate Specificity Gene Expression Regulation, Viral Viral Interference Gene Expression Regulation Immune Evasion

Disciplines and Occupations5

Drug Design Nontherapeutic Human Experimentation Evidence-Based Medicine Research Design Public Health

Anthropology, Education, Sociology and Social Phenomena1

Informed Consent

Technology, Industry, Agriculture2

Polyethylene Glycols Alcoholic Beverages

Humanities2

Morals Moral Obligations

Information Science5

Molecular Sequence Data Amino Acid Sequence Base Sequence Questionnaires Decision Support Techniques

Health Care28

Treatment Outcome Post-Exposure Prophylaxis Insurance Benefits Disease Outbreaks Clinical Trials as Topic Risk Factors Randomized Controlled Trials as Topic Risk Assessment Cost-Benefit Analysis Medical Errors Health Benefit Plans, Employee Retrospective Studies Follow-Up Studies Prospective Studies Needle-Exchange Programs Mass Screening Informed Consent Questionnaires Survival Analysis Patient Safety Medication Errors Patient Selection Safety Management Patient Harm Double-Blind Method Practice Guidelines as Topic Public Health Cohort Studies

Geographicals2

United States Great Britain

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care Geographicals

Antiviral Agents Harm Reduction Virus Replication Acyclovir Organophosphonates Rimantadine Amantadine Drug Resistance, Viral Trifluridine Oseltamivir Viral Plaque Assay Influenza, Human Interferons Nucleosides Ribavirin Zanamivir Ganciclovir Hepacivirus Cell Line Cytosine Virus Diseases Vero Cells Foscarnet Interferon-alpha Prodrugs HIV-1 Cercopithecus aethiops Cytomegalovirus Idoxuridine RNA, Viral Organophosphorus Compounds Zalcitabine Simplexvirus Anti-HIV Agents Viruses Ribonucleosides Adenine Influenza A Virus, H1N1 Subtype Influenza B virus 2-Aminopurine Treatment Outcome Post-Exposure Prophylaxis Influenza A virus Orthomyxoviridae Hepatitis B virus Herpes Simplex Zidovudine Lamivudine Reverse Transcriptase Inhibitors Pyrans Viral Proteins Inhibitory Concentration 50 Cytomegalovirus Infections Drug Therapy, Combination Hepatitis B, Chronic Viral Nonstructural Proteins Hepatitis C, Chronic HIV Herpesvirus 1, Human Molecular Sequence Data Arabinonucleotides Interferon Type I Vidarabine Phosphate DNA, Viral Drug Evaluation, Preclinical Arabinofuranosyluracil Virus Internalization Time Factors Hepatitis C Vidarabine Viral Load Drug Design Cells, Cultured Cytopathogenic Effect, Viral Herpesviridae Herpesvirus 2, Human Neuraminidase Structure-Activity Relationship Enterovirus A, Human Eye Infections, Viral Interferon-beta Insurance Benefits Hepatitis B HIV Infections Dideoxynucleosides Isoxazoles Influenza Vaccines Herpes Zoster Myxovirus Resistance Proteins Influenza A Virus, H3N2 Subtype Influenza A Virus, H5N1 Subtype Replicon Protease Inhibitors Guanine Amino Acid Sequence Virus Activation Herpesvirus 3, Human Vesicular stomatitis Indiana virus Vaccinia virus Herpesviridae Infections

No FAQ available that match "benefits and harms antiviral agents"